Form 4: Paylocity Holding Corp Director Steven I. Sarowitz Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Steven I. Sarowitz of Paylocity Holding Corp sold shares of common stock on November 6, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • On November 6, 2024, Steven I. Sarowitz, a director of Paylocity Holding Corp, sold shares of the company's common stock.
  • The sales were executed under a pre-approved 10b5-1 trading plan adopted on September 15, 2023.
  • A total of 33,039 shares were sold at prices ranging from $201.92 to $213.93.
  • Following these transactions, Sarowitz directly owns 9,418,825 shares of Paylocity common stock.
  • Additionally, Sarowitz indirectly owns 20,000 shares through the Jessica P. Sarowitz Declaration of Trust.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider trading activity. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for corporate insiders to use 10b5-1 plans to sell shares over time to avoid accusations of trading on non-public information. The impact on the stock price is usually minimal unless the sales are unusually large or frequent.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
  • The use of a 10b5-1 plan is a common strategy among corporate executives to diversify their holdings while avoiding potential insider trading concerns, similar to practices seen at companies like Microsoft (MSFT) and Apple (AAPL).

Stakeholder Impact

  • The share sales by a director could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
  • The impact on employees, customers, suppliers, and creditors is likely to be negligible.

Key Dates

DateDescription
2023-09-15Date of adoption of the 10b5-1 trading plan.
2024-11-06Date of the reported transactions (share sales).
2024-11-08Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.